CNS DRUGS（中枢神经系统药物杂志）影响因子_期刊投稿发表

期刊简介

CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:- Overviews of contentious or emerging issues.- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

CNS药物促进临床精神病学和神经病学学科内的合理药物治疗。该杂志包括：-有争议的或新出现的问题的概述。全面的叙述性综述，提供了关于管理神经和精神疾病的药理学方法的权威信息来源。系统性综述，使用PRISMA声明中概述的明确、系统的方法，整理经验证据以回答特定的研究问题。Adis Drug评论的性质和地方在治疗中的新的和已建立的药物在神经病学和精神病学。报告与临床实践密切相关的精心设计的研究结果的原创研究文章，如临床药效学和药代动力学研究、临床试验、荟萃分析、结局研究、药物经济学和药物流行病学研究。（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表播客和动画）可以与文章一起发布;目的是提高刊物的知名度、读者群和教育价值。此外，在CNS Drugs上发表的文章可能附有简明扼要的总结，以帮助对该领域有一定了解但没有深入专业知识的读者了解重要的医学进展。

《CNS DRUGS》期刊已被查看：次

分区信息